Rayner, C. K., Wu, T., Aroda, V. R., Whittington, C., Kanters, S., Guyot, P., . . . Horowitz, M. (2020). Gastrointestinal adverse events with insulin glargine/lixisenatide fixed‐ratio combination versus glucagon‐like peptide‐1 receptor agonists in people with type 2 diabetes mellitus: A network meta‐analysis. Diabetes Obes Metab.

Rayner, Christopher K., Tongzhi Wu, Vanita R. Aroda, Craig Whittington, Steve Kanters, Patricia Guyot, Alka Shaunik, و Michael Horowitz. "Gastrointestinal Adverse Events With Insulin Glargine/lixisenatide Fixed‐ratio Combination Versus Glucagon‐like Peptide‐1 Receptor Agonists in People With Type 2 Diabetes Mellitus: A Network Meta‐analysis." Diabetes Obes Metab 2020.

Rayner, Christopher K., et al. "Gastrointestinal Adverse Events With Insulin Glargine/lixisenatide Fixed‐ratio Combination Versus Glucagon‐like Peptide‐1 Receptor Agonists in People With Type 2 Diabetes Mellitus: A Network Meta‐analysis." Diabetes Obes Metab 2020.